Beau Kilmer is the Co-Director of the RAND Drug Policy Research Center. His primary fields of interest are illicit markets, community corrections, drug treatment, and technologies that enable what he calls DIRECT surveillance (Drug and alcohol use Information from REmote and Continuous Testing). He is the Co-Principal Investigator on two projects at RAND, one to improve data on illegal drug markets and crime in Europe (funded by the Europena Commission), and another which focuses on the community-level effects of drug treatment (funded by RWJF). Dr. Kilmer is also working on two projects to estimate the economic cost of drug use and is calculating the size of illicit drug markets for the European Commission. Before earning his doctorate, Beau received a Judicial Administration Fellowship that supported his work with the San Francisco Drug Court.